OLIGODENDROGLIOMA
Clinical trials for OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cells and immunotherapy join forces against childhood brain tumors
Disease control OngoingThis early-stage trial tests a new approach for children whose high-grade glioma has come back after standard treatments. It combines specially grown stem cells with an immunotherapy drug called nivolumab. The main goals are to see if the treatment is safe and possible to deliver…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 17, 2026 00:29 UTC
-
New combo therapy targets hard-to-treat brain tumors
Disease control OngoingThis early-stage study tests whether combining two drugs—vorasidenib and pembrolizumab—can help people with a specific type of brain tumor (IDH-1 mutant glioma) that has come back or is growing. About 60 adults with grade 2 or 3 tumors will receive the treatment before and after …
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Virus therapy takes on brain cancer in early trial
Disease control OngoingThis early-stage study tests a genetically engineered virus (rQNestin34.5v.2) that is injected directly into recurrent brain tumors to see if it is safe and what dose works best. About 62 adults with certain types of brain cancer that have come back or worsened are taking part. T…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Brain cancer gene therapy trial pulled before it began
Disease control TerminatedThis study aimed to see if adding a special virus (Toca 511) and a drug (Toca FC) to standard chemotherapy and radiation could help people with a newly diagnosed aggressive brain cancer called glioblastoma. The virus was designed to make tumor cells convert Toca FC into a cancer-…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
New microscope could help surgeons spot brain tumor borders in real time
Diagnosis TerminatedThis early study tests a new imaging technique called qOBM that may help brain surgeons see tumor edges more clearly during surgery. About 24 adults with certain brain tumors (glioblastoma, astrocytoma, or oligodendroglioma) will have the device used during their planned tumor re…
Matched conditions: OLIGODENDROGLIOMA
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated May 28, 2026 12:04 UTC
-
Brain tumor patients may keep more memory with proton therapy, new study hopes to prove
Symptom relief OngoingThis study compares two types of radiation therapy—proton beam and photon beam (IMRT)—to see which one better preserves thinking and memory in people with IDH mutant grade II or III gliomas. About 120 participants will be randomly assigned to one of the two treatments. The goal i…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC